A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma

Abroad (travel likely)RecruitingPHASE2

Conditions

DIPG

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tata Memorial Hospital, Mumbai, Maharashtra, India
Contact: Study coordinator (Dr Rahul Krishnatry, MD) · krishnatry@gmail.com · 022-24177000

Study leads

Rahul Krishnatry, Dr
Principal Investigator
Tata Memorial Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Atypical Teratoid/Rhabdoid Tumor · Embryonal Tumor With Multilayered Rosettes · Ewing Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Little Rock, United States

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Solid Tumor Cancer · Medulloblastoma · High Risk Neuroblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Boadilla del Monte, Spain

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Diffuse Intrinsic Pontine Gliomas (DIPG) · Progressive DIPG · Refractory DIPG

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Washington D.C., United States

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

Glioblastoma Multiforme · Anaplastic Astrocytoma · Fibrillary Astrocytomas

Abroad (travel likely)RecruitingPHASE1, PHASE2

Miami, United States